Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics, 2019 Study -

June 7, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Jun 7, 2019--

The “Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics” report has been added to’s offering.

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) covers innovations and new developments across global digital health, biomanufacturing, pharmaceutical, biological, genomic and diagnostic landscapes. This TOE also analyzes research advances across immune-oncology and depression.


The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery, and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Companies Mentioned

  • Akili Interactive Labs
  • Codiak Biosciences
  • Molecular Templates
  • SystImmune
  • 4D Molecular Therapeutics
  • Sherlock Biosciences
  • Ares Genetics
  • T2 Biosystems
  • 1DROP Diagnostics
  • Karius Inc.
  • DAYZERO Diagnostics
  • Sight Diagnostics
  • Immunetics Inc.
  • ERADA Technology Alliance Limited
  • Paragon Bioservices
  • BrammerBio
  • Chr Hansen
  • Inivata
  • Royal College of Surgeons
  • MedGenesis Therapeutix
  • Domainex
  • Biogen
  • University of California, San Francisco
  • Five Prime Therapeutics
  • StemoniX
  • University of North Carolina

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900


Related Topics:Genomics,E-Healthcare,Biopharmaceuticals



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 06/07/2019 09:00 AM/DISC: 06/07/2019 09:01 AM